This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Seasoned Healthcare Entrepreneur Brings Strong Track Record in Building Highly Successful Companies TORONTO,
July 5, 2012 /PRNewswire/ -
Diversinet Corp. (TSX Venture: DIV, OTCBB: DVNTF), a leader in secure mobile health, has appointed
Bret W. Jorgensen as chairman of the board succeeding
Albert Wahbe, who has retired as chairman but remains a member of the board.
Jorgensen brings over 20 years of experience as a healthcare entrepreneur and corporate transformation executive to Diversinet. He has deep leadership experience in rapid-growth, technology-enabled health services organizations and a proven record in corporate fundraising, strategy execution and value creation. Jorgensen was most recently the CEO of MDVIP, a personalized healthcare company that offers primary and preventive care services in 40 states. He left the company in early 2010 after a successful sale to Procter & Gamble. He currently serves as director of MDVIP.
Previously, as CEO, he restructured InSight Health, a diagnostic-imaging business with more than 200 service sites. Earlier in his career, Jorgensen was co-founder and president of TheraTx Health Services, a large, fast-growing healthcare services company with 240 sites, 5,000 employees and an innovative point-of-care HCIT solution, TheraSys. TheraTx was recognized as the 2
nd fastest growing public company by Inc. magazine and Jorgensen received the "Entrepreneur of the Year" Award in Healthcare for this effort. He left the company after a successful sale to Kindred.
Jorgensen also currently serves as chairman of Crossover Health, an innovative worksite health provider, and a board member of the Kravis Leadership Institute. He is a strategic advisor to Qualcomm Life, which offers the 2net platform for mobile health, and Hello Health, which provides an unique patient engagement platform, and has served as a director of several other public and private healthcare companies.